Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-03Clinical Trial Update: A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase [Phase 2]
A Phase 2 pivotal study evaluating HQP1351 in patients with chronic myeloid leukemia in chronic phase has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response. [Phase 2]
Phase 2 study evaluating the efficacy and safety of asciminib in combination with imatinib in patients with chronic-phase chronic myeloid le…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib [Phase 2]
Phase 2 trial update on ponatinib in adults with imatinib-resistant chronic-phase chronic myeloid leukemia, describing its activity and safe…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma [Phase 2]
Phase 2 trial evaluating dendritic cell therapy for acute myeloid leukemia, chronic myeloid leukemia, and multiple myeloma reports efficacy …
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy
This completed clinical trial update analyzes real-world treatment patterns and outcomes for patients with chronic myeloid leukemia who are …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: MargheRITA (Remote Intelligence for Therapeutic Adherence) [NA]
A completed clinical trial named MargheRITA (Remote Intelligence for Therapeutic Adherence) sponsored by Advice Pharma Group srl studied tre…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update on a Triplex CMV vaccine designed to prevent CMV infection in patients undergoing hematopoietic stem cell tran…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML [Phase 2]
Phase 2 clinical trial evaluating CD34-selected allogeneic hematopoietic stem cell transplantation with myeloablative conditioning plus CD8+…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies [Phase 2]
Phase 2 trial evaluating post-transplantation bendamustine and cyclophosphamide in refractory myeloid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS [Phase 1]
Phase I study of CYC140, a PLK-1 inhibitor, in advanced leukemias and myelodysplastic syndromes has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response [Phase 3]
Phase 3 clinical trial evaluating optimization of tyrosine kinase inhibitor therapy and quality of life in Philadelphia-positive chronic mye…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia [Phase 2]
A Phase 2 clinical trial evaluating pegylated interferon alfa-2b in combination with nilotinib to augment complete molecular response in chr…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec) [Phase 2]
Phase II study evaluating decitabine in chronic myeloid leukemia in blast phase patients refractory to imatinib; the trial status is complet…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias [Phase 1, Phase 2]
An early-phase study of escalating doses of AT9283 for various leukemias has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies [Phase 1, Phase 2]
Phase 1/Phase 2 trial update reporting safety and anti-leukemic activity of vodobatinib (K0706) in Ph+ chronic myeloid leukemia patients res…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression [Phase 3]
Phase 3 trial evaluating haploidentical allogeneic peripheral blood transplantation with analysis of checkpoint immune regulator expression;…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation [Phase 3]
Phase 3 trial results for asciminib as monotherapy in chronic myeloid leukemia in chronic phase, including patients with and without the T31…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers [Phase 2]
A Phase 2 clinical trial update on haploidentical stem cell transplantation for multiple hematologic cancers, with the study status reported…
-
CLINICAL_TRIALS trial_result · 2024-04-30Clinical Trial Update: Safety And Efficacy Of Bosutinib
This Clinical Trial Update reports on the safety and efficacy outcomes of bosutinib in patients with chronic myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients [Phase 2]
A Phase 2 study evaluating azacitidine, venetoclax, and flumatinib in newly diagnosed Ph-positive acute leukemia and CML-AP/BP; the trial ha…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients [Phase 1, Phase 2]
A phase 1/2 trial evaluated the safety and efficacy of bosutinib in combination with atezolizumab in adults with newly diagnosed chronic mye…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study [Phase 4]
Phase 4 trial update on allowing access to nilotinib for patients already receiving nilotinib in a Novartis-sponsored study; study status co…
-
CLINICAL_TRIALS trial_result · 2024-01-31Clinical Trial Update: CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant [Phase 1]
Phase 1 trial evaluating the CMV-MVA Triplex vaccine given to stem cell donors to prevent cytomegalovirus viremia in recipients of allogenei…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy [Phase 2]
Phase 2 clinical trial update for MGTA-456 in high-risk hematologic malignancies; results were posted in 2024 and the study is currently act…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating natural killer cells as part of donor stem cell transplantation for various myeloid leukemias and myelodysplastic…